Article(id=1330233441578234287, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233409554722961, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.12.013, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1692806400000, receivedDateStr=2023-08-24, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795081967013, onlineDateStr=2026-11-19, pubDate=1702137600000, pubDateStr=2023-12-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795081967013, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795081967013, creator=13701087609, updateTime=1795081967013, updator=13701087609, issue=Issue{id=1330233409554722961, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='12', pageStart='1687', pageEnd='1822', issueExtLink='null', onlineDate='null', pubDate='1702137600000', pubDateStr='2023-12-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795081959379, creator='13701087609', updateTime=1795082630543, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330236225149055059, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233409554722961, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330236225149055060, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233409554722961, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1774, endPage=1780, ext={EN=ArticleExt(id=1330233441779560880, articleId=1330233441578234287, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Application and Concerns of Reverse Engineering in the Development of Generic Drugs, columnId=1322624444787438528, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Pharmaceutical Management & Information, runingTitle=null, highlight=null, articleAbstract=null, authors=Jili SHEN1, Qing GONG1, Chunmeng SUN2, Xinfang ZHANG1, *, authorsList=Jili SHEN, Qing GONG, Chunmeng SUN, Xinfang ZHANG, authorCompany=null, correspAuthors=Xinfang ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330233442610033073, articleId=1330233441578234287, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=逆向工程法在仿制药开发中的应用及关注点, columnId=1322624444934239170, journalTitle=中国医药工业杂志, columnName=药学管理与信息, runingTitle=null, highlight=null, articleAbstract=

在我国仿制药一致性评价政策的推动下,随着ICH M9等指导原则的实施,对参比制剂处方的正确解析直接决定了是否可豁免仿制药的生物等效试验,且关系到仿制药与参比制剂生物等效试验的成败。该文全方位阐述了如何将逆向工程法用于参比制剂解析,包括处方、生产工艺及包装等方面,并结合审评经验进行案例分析,旨在引导业界探索更多的逆向工程技术用于开发高质量的仿制药,以期加速仿制药上市。

, authors=申际丽1, 龚青1, 孙春萌2, 张新房1, *, authorsList=申际丽, 龚青, 孙春萌, 张新房, authorCompany=null, correspAuthors=张新房, authorNote=

申际丽(1987—),女,硕士,审评员,从事化药药学的技术审评工作。

, correspAuthorsNote=
张新房(1979—),男,副主任药师,主审审评员,从事化药药学的技术审评工作。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=0YU83SOFFw91SOmtFLMaeg==, magXml=TD09OjcC5XesUP/Qz9d3ug==, pdfUrl=null, pdf=0kvKjVPa4Qts8PN/S2FDIg==, pdfFileSize=1540702, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=otP1TQMpdCVKsCU3thoNgg==, mapNumber=null, fund=null)}, authors=[Author(id=1330233443931238841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233444002542011, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233443931238841, language=EN, stringName=Jili SHEN, firstName=Jili, middleName=null, lastName=SHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233444086428092, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233443931238841, language=CN, stringName=申际丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

申际丽(1987—),女,硕士,审评员,从事化药药学的技术审评工作。

"}, bioImg=null, bioContent=

申际丽(1987—),女,硕士,审评员,从事化药药学的技术审评工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233443738300850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, xref=1., ext=[AuthorCompanyExt(id=1330233443746689459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1330233443755078068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1330233444166119870, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233444254200256, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233444166119870, language=EN, stringName=Qing GONG, firstName=Qing, middleName=null, lastName=GONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233444325503425, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233444166119870, language=CN, stringName=龚青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233443738300850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, xref=1., ext=[AuthorCompanyExt(id=1330233443746689459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1330233443755078068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1330233444388417987, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233444463915461, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233444388417987, language=EN, stringName=Chunmeng SUN, firstName=Chunmeng, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.NMPA Key Lab. for Research and Evaluation of Pharmaceutical Preparations and Excipients, Dept. of Pharmaceuticals, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233444543607238, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233444388417987, language=CN, stringName=孙春萌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国药科大学药学院药剂系,国家药品监督管理局药物制剂及辅料研究与评价重点实验室,江苏 南京 210009, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233443830575541, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, xref=2., ext=[AuthorCompanyExt(id=1330233443838964150, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443830575541, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.NMPA Key Lab. for Research and Evaluation of Pharmaceutical Preparations and Excipients, Dept. of Pharmaceuticals, School of Pharmacy, China Pharmaceutical University, Nanjing 210009), AuthorCompanyExt(id=1330233443847352759, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443830575541, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学药学院药剂系,国家药品监督管理局药物制剂及辅料研究与评价重点实验室,江苏 南京 210009)])]), Author(id=1330233444610716104, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhangxf@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233444686213578, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233444610716104, language=EN, stringName=Xinfang ZHANG, firstName=Xinfang, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233444749128139, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233444610716104, language=CN, stringName=张新房, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233443738300850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, xref=1., ext=[AuthorCompanyExt(id=1330233443746689459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1330233443755078068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.国家药品监督管理局药品审评中心,北京 100022)])])], keywords=[Keyword(id=1330233444841402828, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, language=CN, orderNo=1, keyword=逆向工程法), Keyword(id=1330233444912705997, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, language=CN, orderNo=2, keyword=仿制药), Keyword(id=1330233444984009167, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, language=CN, orderNo=3, keyword=生物等效性), Keyword(id=1330233445038535120, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, language=CN, orderNo=4, keyword=参比制剂)], refs=[Reference(id=1330233445130809809, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=HAL. Scaling up and reverse engineering acquisition of industrial knowledge by copying drugs in Brazil [EB/OL]. [2023-05-08]. https://shs.hal.science/halshs-02024011/document., articleTitle=null, refAbstract=null), Reference(id=1330233445193724370, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH. M9: Biopharmaceutics Classification System-Based Biowaivers and Q&As on Biopharmaceutics Classification System-Based Biowaivers [EB/OL]. (2019-11-20)[2023-05-08]. https://www.ich.org/page/multidisciplinary-guidelines., articleTitle=null, refAbstract=null), Reference(id=1330233445269221843, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学药品注射剂仿制药质量和疗效一致性评价技术要求[EB/OL].(2020-05-14)[2023-05-08].https://www.cde.org.cn/main/news/viewInfoCommon/d9c6f118b773f54e8feba3519bf78a11., articleTitle=null, refAbstract=null), Reference(id=1330233445348913620, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学药品注射剂(特殊注射剂)仿制药质量和疗效一致性评价技术要求[EB/OL].(2020-5-14)[2023-05-08].https://www.cde.org.cn/main/news/viewInfoCommon/d9c6f118b773f54e8feba3519bf78a11., articleTitle=null, refAbstract=null), Reference(id=1330233445407633877, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.《化学药品仿制药溶液型滴眼剂药学研究技术指导原则》[EB/OL].(2023-02-16)[2023-05-08].https://www.cde.org.cn/main/news/viewInfoCommon/4a37370c92e2711fa80a3689700d7991., articleTitle=null, refAbstract=null), Reference(id=1330233445470548439, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学药品吸入液体制剂药学研究技术要求(2021年1月)[EB/OL].(2021-11-25)[2023-05-08].https://www.cde.org.cn/main/news/viewInfoCommon/415f88b7e754c778d3e85e55042eff4e., articleTitle=null, refAbstract=null), Reference(id=1330233445550240216, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.皮肤外用化学仿制药技术研究技术指导原则(试行)[EB/OL].(2021-03-16)[2023-05-08].https://www.cde.org.cn/main/news/viewInfoCommon/4e790f4ad1cb21091e5a8bf4a107c535., articleTitle=null, refAbstract=null), Reference(id=1330233445646709209, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules [EB/OL]. (2022-10-03)[2023-05-08]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/size-shape-and-other-physical-attributes-generic-tablets-and-capsules., articleTitle=null, refAbstract=null), Reference(id=1330233445713818074, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=BANSAL A K, KORADIA V. The role of reverse engineering in the development of generic formulations[J]. Pharm Technol, 2005, 29(8): 50-55., articleTitle=null, refAbstract=null), Reference(id=1330233445764149723, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=洪晓轩,王增明,高静,等.逆向工程在咖啡因片制剂开发中的应用[J].国际药学研究杂志,2020,47(9):756-764., articleTitle=null, refAbstract=null), Reference(id=1330233445827064284, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Guidance for industry: immediate release solid oral dosage forms scale-up and postapproval changes: chemistry, manufacturing, and controls, in vitro dissolution testing, and in vivo bioequivalence documentation [EB/OL]. [2023-05-08]. https://www.fda.gov/regulatory-Information/search-fda-guidance-documents/default.htm., articleTitle=null, refAbstract=null), Reference(id=1330233445885784541, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. SUPAC-IR Questions and Answers about SUPAC-IR Guidance [EB/OL]. [2023-05-08]. https://www.fda.gov/regulatory-Information/search-fda-guidance-documents/default.htm., articleTitle=null, refAbstract=null), Reference(id=1330233445952893406, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=PMDA. Guideline for Bioequivalence Studies for Different Strengths of Oral Solid Dosage [EB/OL]. (2020-3-19)[2023-05-08]. https://www.nihs.go.jp/drug/index-E.html#Quality., articleTitle=null, refAbstract=null), Reference(id=1330233446011613663, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=PMDA. Guideline for Bioequivalence Studies for Formulation Changes of Oral Solid Dosage Forms [EB/OL]. (2020-3-19)[2023-05-08]. https://www.nihs.go.jp/drug/index-E.html#Quality., articleTitle=null, refAbstract=null), Reference(id=1330233446074528224, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=赵娇娇.软膏剂Abreva成分检测的逆向工程技术研究[D].杭州:中国计量大学,硕士学位论文,2016., articleTitle=null, refAbstract=null), Reference(id=1330233446141637089, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. ANDA Submissions-Refuse-to-Receive Standards Rev. 2 [EB/OL]. [2023-05-08]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/anda-submissions-refuse-receive-standards-rev2., articleTitle=null, refAbstract=null), Reference(id=1330233446208745954, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use [EB/OL]. [2023-11-15]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-waiver-requests-ph-adjusters-generic-drug-products-intended-parenteral-ophthalmic-or., articleTitle=null, refAbstract=null), Reference(id=1330233446267466211, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=WHO. Expert Committee on Specifications for Pharmaceutical Preparations: forty-ninth report [EB/OL]. [2023-05-08]. https://iris.who.int/bitstream/handle/10665/44291/WHO_TRS_957_eng.pdf., articleTitle=null, refAbstract=null), Reference(id=1330233446326186468, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学仿制药注射剂过量灌装研究技术指导原则(征求意见稿)[EB/OL].(2023-09-28)[2023-11-15].https://www.cde.org.cn/main/news/viewInfoCommon/d1903177899d450b9084ecd40194c34f., articleTitle=null, refAbstract=null), Reference(id=1330233446389101029, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products [EB/OL]. [2023-05-08]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/allowable-excess-volume-and-labeled-vial-fill-size-injectable-drug-and-biological-products., articleTitle=null, refAbstract=null), Reference(id=1330233446468792806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA. Annex Summary of Product Characteristics [EB/OL]. [2023-05-08]. https://www.ema.europa.eu/en/documents/product-information/mycamine-epar-product-information_en.pdf., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330233443738300850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, xref=1., ext=[AuthorCompanyExt(id=1330233443746689459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1330233443755078068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.国家药品监督管理局药品审评中心,北京 100022)]), AuthorCompany(id=1330233443830575541, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, xref=2., ext=[AuthorCompanyExt(id=1330233443838964150, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443830575541, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.NMPA Key Lab. for Research and Evaluation of Pharmaceutical Preparations and Excipients, Dept. of Pharmaceuticals, School of Pharmacy, China Pharmaceutical University, Nanjing 210009), AuthorCompanyExt(id=1330233443847352759, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443830575541, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学药学院药剂系,国家药品监督管理局药物制剂及辅料研究与评价重点实验室,江苏 南京 210009)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.12.013, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.12.013, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.12.013, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.12.013, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1702137600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
逆向工程法在仿制药开发中的应用及关注点
申际丽 1 , 龚青 1 , 孙春萌 2 , 张新房 1, *
中国医药工业杂志 | 药学管理与信息 2023,54(12): 1774-1780
收起
收藏切换
中国医药工业杂志 |药学管理与信息 2023 , 54 (12) : 1774 -1780
逆向工程法在仿制药开发中的应用及关注点
全屏
[Author(id=1330233443931238841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233444002542011, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233443931238841, language=EN, stringName=Jili SHEN, firstName=Jili, middleName=null, lastName=SHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233444086428092, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233443931238841, language=CN, stringName=申际丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

申际丽(1987—),女,硕士,审评员,从事化药药学的技术审评工作。

"}, bioImg=null, bioContent=

申际丽(1987—),女,硕士,审评员,从事化药药学的技术审评工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233443738300850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, xref=1., ext=[AuthorCompanyExt(id=1330233443746689459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1330233443755078068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1330233444166119870, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233444254200256, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233444166119870, language=EN, stringName=Qing GONG, firstName=Qing, middleName=null, lastName=GONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233444325503425, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233444166119870, language=CN, stringName=龚青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233443738300850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, xref=1., ext=[AuthorCompanyExt(id=1330233443746689459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1330233443755078068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1330233444388417987, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233444463915461, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233444388417987, language=EN, stringName=Chunmeng SUN, firstName=Chunmeng, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.NMPA Key Lab. for Research and Evaluation of Pharmaceutical Preparations and Excipients, Dept. of Pharmaceuticals, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233444543607238, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233444388417987, language=CN, stringName=孙春萌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国药科大学药学院药剂系,国家药品监督管理局药物制剂及辅料研究与评价重点实验室,江苏 南京 210009, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233443830575541, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, xref=2., ext=[AuthorCompanyExt(id=1330233443838964150, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443830575541, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.NMPA Key Lab. for Research and Evaluation of Pharmaceutical Preparations and Excipients, Dept. of Pharmaceuticals, School of Pharmacy, China Pharmaceutical University, Nanjing 210009), AuthorCompanyExt(id=1330233443847352759, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443830575541, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学药学院药剂系,国家药品监督管理局药物制剂及辅料研究与评价重点实验室,江苏 南京 210009)])]), Author(id=1330233444610716104, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhangxf@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233444686213578, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233444610716104, language=EN, stringName=Xinfang ZHANG, firstName=Xinfang, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233444749128139, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, authorId=1330233444610716104, language=CN, stringName=张新房, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233443738300850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, xref=1., ext=[AuthorCompanyExt(id=1330233443746689459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1330233443755078068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233441578234287, companyId=1330233443738300850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.国家药品监督管理局药品审评中心,北京 100022)])])]
申际丽1, 龚青1, 孙春萌2, 张新房1, *
作者信息
  • 1.国家药品监督管理局药品审评中心,北京 100022
  • 2.中国药科大学药学院药剂系,国家药品监督管理局药物制剂及辅料研究与评价重点实验室,江苏 南京 210009
通讯作者:
张新房(1979—),男,副主任药师,主审审评员,从事化药药学的技术审评工作。E-mail:
作者简介:

申际丽(1987—),女,硕士,审评员,从事化药药学的技术审评工作。

Application and Concerns of Reverse Engineering in the Development of Generic Drugs
Jili SHEN1, Qing GONG1, Chunmeng SUN2, Xinfang ZHANG1, *
Affiliations
  • 1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022
  • 2.NMPA Key Lab. for Research and Evaluation of Pharmaceutical Preparations and Excipients, Dept. of Pharmaceuticals, School of Pharmacy, China Pharmaceutical University, Nanjing 210009
出版时间: 2023-12-10 doi: 10.16522/j.cnki.cjph.2023.12.013
文章导航
收藏切换

在我国仿制药一致性评价政策的推动下,随着ICH M9等指导原则的实施,对参比制剂处方的正确解析直接决定了是否可豁免仿制药的生物等效试验,且关系到仿制药与参比制剂生物等效试验的成败。该文全方位阐述了如何将逆向工程法用于参比制剂解析,包括处方、生产工艺及包装等方面,并结合审评经验进行案例分析,旨在引导业界探索更多的逆向工程技术用于开发高质量的仿制药,以期加速仿制药上市。

逆向工程法  /  仿制药  /  生物等效性  /  参比制剂
申际丽, 龚青, 孙春萌, 张新房. 逆向工程法在仿制药开发中的应用及关注点. 中国医药工业杂志, 2023 , 54 (12) : 1774 -1780 . DOI: 10.16522/j.cnki.cjph.2023.12.013
Jili SHEN, Qing GONG, Chunmeng SUN, Xinfang ZHANG. Application and Concerns of Reverse Engineering in the Development of Generic Drugs[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (12) : 1774 -1780 . DOI: 10.16522/j.cnki.cjph.2023.12.013

参考文献 引证文献
排序方式:
[1]
HAL. Scaling up and reverse engineering acquisition of industrial knowledge by copying drugs in Brazil [EB/OL]. [2023-05-08]. https://shs.hal.science/halshs-02024011/document.
[2]
ICH. M9: Biopharmaceutics Classification System-Based Biowaivers and Q&As on Biopharmaceutics Classification System-Based Biowaivers [EB/OL]. (2019-11-20)[2023-05-08]. https://www.ich.org/page/multidisciplinary-guidelines.
[3]
国家药品监督管理局药品审评中心.化学药品注射剂仿制药质量和疗效一致性评价技术要求[EB/OL].(2020-05-14)[2023-05-08].https://www.cde.org.cn/main/news/viewInfoCommon/d9c6f118b773f54e8feba3519bf78a11.
[4]
国家药品监督管理局药品审评中心.化学药品注射剂(特殊注射剂)仿制药质量和疗效一致性评价技术要求[EB/OL].(2020-5-14)[2023-05-08].https://www.cde.org.cn/main/news/viewInfoCommon/d9c6f118b773f54e8feba3519bf78a11.
[5]
国家药品监督管理局药品审评中心.《化学药品仿制药溶液型滴眼剂药学研究技术指导原则》[EB/OL].(2023-02-16)[2023-05-08].https://www.cde.org.cn/main/news/viewInfoCommon/4a37370c92e2711fa80a3689700d7991.
[6]
国家药品监督管理局药品审评中心.化学药品吸入液体制剂药学研究技术要求(2021年1月)[EB/OL].(2021-11-25)[2023-05-08].https://www.cde.org.cn/main/news/viewInfoCommon/415f88b7e754c778d3e85e55042eff4e.
[7]
国家药品监督管理局药品审评中心.皮肤外用化学仿制药技术研究技术指导原则(试行)[EB/OL].(2021-03-16)[2023-05-08].https://www.cde.org.cn/main/news/viewInfoCommon/4e790f4ad1cb21091e5a8bf4a107c535.
[8]
FDA. Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules [EB/OL]. (2022-10-03)[2023-05-08]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/size-shape-and-other-physical-attributes-generic-tablets-and-capsules.
[9]
BANSAL A K, KORADIA V. The role of reverse engineering in the development of generic formulations[J]. Pharm Technol, 2005, 29(8): 50-55.
[10]
洪晓轩,王增明,高静,等.逆向工程在咖啡因片制剂开发中的应用[J].国际药学研究杂志,2020,47(9):756-764.
[11]
FDA. Guidance for industry: immediate release solid oral dosage forms scale-up and postapproval changes: chemistry, manufacturing, and controls, in vitro dissolution testing, and in vivo bioequivalence documentation [EB/OL]. [2023-05-08]. https://www.fda.gov/regulatory-Information/search-fda-guidance-documents/default.htm.
[12]
FDA. SUPAC-IR Questions and Answers about SUPAC-IR Guidance [EB/OL]. [2023-05-08]. https://www.fda.gov/regulatory-Information/search-fda-guidance-documents/default.htm.
[13]
PMDA. Guideline for Bioequivalence Studies for Different Strengths of Oral Solid Dosage [EB/OL]. (2020-3-19)[2023-05-08]. https://www.nihs.go.jp/drug/index-E.html#Quality.
[14]
PMDA. Guideline for Bioequivalence Studies for Formulation Changes of Oral Solid Dosage Forms [EB/OL]. (2020-3-19)[2023-05-08]. https://www.nihs.go.jp/drug/index-E.html#Quality.
[15]
赵娇娇.软膏剂Abreva成分检测的逆向工程技术研究[D].杭州:中国计量大学,硕士学位论文,2016.
[16]
FDA. ANDA Submissions-Refuse-to-Receive Standards Rev. 2 [EB/OL]. [2023-05-08]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/anda-submissions-refuse-receive-standards-rev2.
[17]
FDA. Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use [EB/OL]. [2023-11-15]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-waiver-requests-ph-adjusters-generic-drug-products-intended-parenteral-ophthalmic-or.
[18]
WHO. Expert Committee on Specifications for Pharmaceutical Preparations: forty-ninth report [EB/OL]. [2023-05-08]. https://iris.who.int/bitstream/handle/10665/44291/WHO_TRS_957_eng.pdf.
[19]
国家药品监督管理局药品审评中心.化学仿制药注射剂过量灌装研究技术指导原则(征求意见稿)[EB/OL].(2023-09-28)[2023-11-15].https://www.cde.org.cn/main/news/viewInfoCommon/d1903177899d450b9084ecd40194c34f.
[20]
FDA. Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products [EB/OL]. [2023-05-08]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/allowable-excess-volume-and-labeled-vial-fill-size-injectable-drug-and-biological-products.
[21]
EMA. Annex Summary of Product Characteristics [EB/OL]. [2023-05-08]. https://www.ema.europa.eu/en/documents/product-information/mycamine-epar-product-information_en.pdf.
2023年第54卷第12期
21
2
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.12.013
  • 接收时间:2023-08-24
  • 首发时间:2026-11-19
  • 出版时间:2023-12-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-08-24
基金
作者信息
    1.国家药品监督管理局药品审评中心,北京 100022
    2.中国药科大学药学院药剂系,国家药品监督管理局药物制剂及辅料研究与评价重点实验室,江苏 南京 210009

通讯作者:

张新房(1979—),男,副主任药师,主审审评员,从事化药药学的技术审评工作。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.12.013
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏